Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Alaunos Therapeutics, Inc. (TCRT) Insider Trading Activity
Healthcare • Biotechnology • 1 employees
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.
Total Value
-$6,021.82
Total Shares
-3,000
Average Trade Value
-$3,010.91
Most Active Insider
Vieser Jaime
Total Activity: $6,022
Largest Single Transaction
$4,386
by Vieser Jaime on Dec 31, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Dec 31, 2024 | 2,182 | $4,386 | 26,712 (-8.2%) | Sale | ||
Dec 31, 2024 | 818 | $1,636 | 25,894 (-3.2%) | Sale |